clinical trials

News

Lilly trumpets heart health data with Mounjaro

Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 drugs for diabetes, with new data for Mounjaro on cardiovascular outcomes.

News

GSK suffers a setback with its TIM-3 programme

GSK has become the latest drugmaker to run into difficulties in developing a drug targeting the immune checkpoint receptor TIM-3.

News

Celcuity eyes big market opportunity after breast cancer win

Celcuity shares rocket on a big win for its lead drug gedatolisib in advanced breast cancer, catapulting its value to almost $1.4 billion.

News

Bayer files HER2+ lung cancer drug in China

Bayer files its oral HER2+ lung cancer drug in China, as it extends a race to market with rival Boehringer Ingelheim.

News

Roche expands phase 3 plans for Alzheimer's drug

Roche has added a phase 3 trial of trontinemab, hoping to show it can delay or prevent progression to Alzheimer's symptoms in preclinical patients.

R&D

Evolution Summit 2025 Returns to San Diego promo image

Partner Content

Revolutionising Clinical Trials: Evolution Summit 2025 Retur...

Marcus Evans is proud to announce the Evolution Summit September 2025, an exclusive, invitation-only event bringing together leading clinical trial executives, innovative suppliers

Lilly trumpets heart health data with Mounjaro

GSK suffers a setback with its TIM-3 programme

Celcuity eyes big market opportunity after breast cancer win

Bayer files HER2+ lung cancer drug in China

Roche expands phase 3 plans for Alzheimer's drug

Revolutionising Clinical Trials: Evolution Summit 2025 Retur...

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

clinical trials

Editor's Picks